Enzalutamide in Biochemically Recurrent Prostate Cancer. Reply
N Engl J Med
.
2024 Jan 4;390(1):90-91.
doi: 10.1056/NEJMc2313228.
Authors
Neal D Shore
1
,
Jamal Tarazi
2
,
Stephen J Freedland
3
Affiliations
1
Carolina Urologic Research Center, Myrtle Beach, SC nshore@gsuro.com.
2
Pfizer, San Diego, CA.
3
Cedars-Sinai Medical Center, Los Angeles, CA.
PMID:
38169498
DOI:
10.1056/NEJMc2313228
No abstract available
Publication types
Letter
Comment
MeSH terms
Benzamides
Humans
Male
Nitriles
Phenylthiohydantoin / therapeutic use
Prostatic Neoplasms* / drug therapy
Substances
enzalutamide
Nitriles
Phenylthiohydantoin
Benzamides